{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:05:15Z","timestamp":1790179515387,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-026-02559-0","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:12:49Z","timestamp":1782990769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MYH2 as a Potential Modifier of Clinical Severity in Facioscapulohumeral Muscular Dystrophy"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6869-8802","authenticated-orcid":false,"given":"Ceren","family":"Hang\u00fcl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse Esra","family":"Manguoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haldun","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofcan","family":"Oflaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan Kemal","family":"Y\u00fccel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilmi","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didem Torun","family":"\u00d6zkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahar","family":"Akkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Ceylaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6415-3215","authenticated-orcid":false,"given":"Sibel Berker","family":"Kara\u00fcz\u00fcm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"2559_CR1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.23.11337","author":"KM Armstrong","year":"1993","unstructured":"Armstrong KM, Baldwin RL (1993) Charged histidine affects alpha-helix stability at all positions in the helix by interacting with the backbone charges. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.90.23.11337","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2559_CR2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.204784","author":"TK Bariana","year":"2019","unstructured":"Bariana TK, Labarque V, Heremans J, Thys C, De Reys M, Greene D, Jenkins B, Grassi L, Seyres D, Burden F, Whitehorn D, Shamardina O, Papadia S, Gomez K, Van Geet C, Koulman A, Ouwehand WH, Ghevaert C, Frontini M, Freson K (2019) Sphingolipid dysregulation due to lack of functional KDSR impairs proplatelet formation causing thrombocytopenia. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2018.204784","journal-title":"Haematologica"},{"key":"2559_CR3","doi-asserted-by":"publisher","unstructured":"Blondelle J, Tallapaka K, Seto JT, Ghassemian M, Clark M, Laitila JM, Bournazos A, Singer JD, Lange S (2019) Cullin-3-dependent deregulation of ACTN1 represents a pathogenic mechanism in nemaline myopathy. JCI Insight 4(10). https:\/\/doi.org\/10.1172\/jci.insight.125665","DOI":"10.1172\/jci.insight.125665"},{"key":"2559_CR34","doi-asserted-by":"publisher","unstructured":"Van Den Boogaard ML, Lemmers RJLF, Balog J, Wohlgemuth M, Auranen M, Mitsuhashi S, Van Der Vliet PJ, Straasheijm KR, Van Den Akker RFP, Kriek M, Laurense-Bik MEY, Raz V, Van Ostaijen-Ten Dam MM, Hansson KBM, Van Der Kooi EL, Kiuru-Enari S, Udd B, Van Tol MJD, Nishino I, Van Der Maarel SM (2016) Mutations in DNMT3B modify epigenetic repression of the D4Z4 repeat and the penetrance of facioscapulohumeral dystrophy. Am J Hum Genet 98(5). https:\/\/doi.org\/10.1016\/j.ajhg.2016.03.013","DOI":"10.1016\/j.ajhg.2016.03.013"},{"key":"2559_CR4","doi-asserted-by":"publisher","unstructured":"Cheli S, Fran\u00e7ois S, Bodega B, Ferrari F, Tenedini E, Roncaglia E, Ferrari S, Ginelli E, Meneveri R (2011) Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns. PLoS ONE 6(6). https:\/\/doi.org\/10.1371\/journal.pone.0020966","DOI":"10.1371\/journal.pone.0020966"},{"key":"2559_CR6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v126.23.763.763","author":"H Deguchi","year":"2015","unstructured":"Deguchi H, Sinha RK, Elias DJ, Griffin JH (2015) Exome genotyping links venous thrombosis risk with the skeletal muscle myosin gene cluster and leads to discovery of new family of procoagulant factors. Blood. https:\/\/doi.org\/10.1182\/blood.v126.23.763.763","journal-title":"Blood"},{"key":"2559_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-024-00361-3","author":"A Fox","year":"2024","unstructured":"Fox A, Oliva J, Vangipurapu R, Sverdrup FM (2024) SIX transcription factors are necessary for the activation of DUX4 expression in facioscapulohumeral muscular dystrophy. Skelet Muscle. https:\/\/doi.org\/10.1186\/s13395-024-00361-3","journal-title":"Skelet Muscle"},{"key":"2559_CR5","doi-asserted-by":"publisher","unstructured":"de la Fuente-Munoz E, Van Den Rym A, Garc\u00eda-Solis B, Ochoa Grull\u00f3n J, Guevara-Hoyer K, Fern\u00e1ndez-Arquero M, Gal\u00e1n D\u00e1vila L, Mat\u00edas-Gui\u00fa J, S\u00e1nchez-Ram\u00f3n S, P\u00e9rez de Diego R (2022) Case report: novel STIM1 gain-of-function mutation in a patient with TAM\/STRMK and immunological involvement. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.917601","DOI":"10.3389\/fimmu.2022.917601"},{"key":"2559_CR8","doi-asserted-by":"publisher","unstructured":"Geng LN, Yao Z, Snider L, Fong AP, Cech JN, Young JM, vanderMaarel SM, Ruzzo WL, Gentleman RC, Tawil R, Tapscott SJ (2012) DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev Cell 22(1). https:\/\/doi.org\/10.1016\/j.devcel.2011.11.013","DOI":"10.1016\/j.devcel.2011.11.013"},{"key":"2559_CR9","doi-asserted-by":"publisher","unstructured":"Hamanaka K, \u0160ikrov\u00e1 D, Mitsuhashi S, Masuda H, Sekiguchi Y, Sugiyama A, Shibuya K, Lemmers RJLF, Goossens R, Ogawa M, Nagao K, Obuse C, Noguchi S, Hayashi YK, Kuwabara S, Balog J, Nishino I, Van Der Maarel SM (2020) Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy. Neurology 94(23). https:\/\/doi.org\/10.1212\/WNL.0000000000009617","DOI":"10.1212\/WNL.0000000000009617"},{"key":"2559_CR13","doi-asserted-by":"publisher","unstructured":"Hang\u00fcl C, Bozkurt S, Bilge U, \u00d6zdem S, Altunba\u015f H, Uysal H, Ko\u00e7 F, Kara\u00fcz\u00fcm SB (2020) The ratios of estradiol and progesterone to testosterone influence the severity of facioscapulohumeral muscular dystrophy. Neurol Sci Neurophysiol 37(4). https:\/\/doi.org\/10.4103\/NSN.NSN_37_20","DOI":"10.4103\/NSN.NSN_37_20"},{"issue":"3","key":"2559_CR14","doi-asserted-by":"publisher","first-page":"702","DOI":"10.17826\/cumj.1736413","volume":"50","author":"C Hang\u00fcl","year":"2025","unstructured":"Hang\u00fcl C, \u015eahan \u00d6B, Kara\u00fcz\u00fcm S, Sauer E, Uysal H, Ko\u00e7 F (2025) Chromosome 4q D4Z4 contraction status in Turkish patients with facioscapulohumeral muscular dystrophy. Cukurova Med J 50(3):702\u2013711. https:\/\/doi.org\/10.17826\/cumj.1736413","journal-title":"Cukurova Med J"},{"key":"2559_CR10","doi-asserted-by":"publisher","DOI":"10.1515\/TJB-2020-0351","author":"C Hangul","year":"2021","unstructured":"Hangul C, Celik EG, Kaya H, Eroglu O, Uysal H, Karauzum SB (2021) Estradiol differentially regulates DUX4, \u03b2-catenin and PAX3\/PAX7 in primary myoblasts of facioscapulohumeral muscular dystrophy patients. Turk J Biochem. https:\/\/doi.org\/10.1515\/TJB-2020-0351","journal-title":"Turk J Biochem"},{"key":"2559_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.16196","author":"C Hangul","year":"2024","unstructured":"Hangul C, Ozcan F, Darbas S, Uysal H, Koc AF, Berker Karauzum S (2024) Progesterone may be a regulator and B12 could be an indicator of the proximal D4Z4 repeat methylation status on 4q35ter. J Neurochem. https:\/\/doi.org\/10.1111\/jnc.16196","journal-title":"J Neurochem"},{"key":"2559_CR12","doi-asserted-by":"publisher","unstructured":"Hangul C, Ozyurt OK, Baldi S, Colak D, Tokta O, Pekcan T, Bertorello S, Pallecchi M, Koc F, Dalokay C, Uysal H, Gulkesen KH, Ozcan F, Bartolucci G, Karauzum SB, Amedei A (2025) Gut Microbiota and Short-Chain Fatty Acid Profiles in Facioscapulohumeral Dystrophy: Associations with Epigenetic Alterations. Can J Neurol Sci \/ J Canadien Des Sci Neurologiques 1\u201312. https:\/\/doi.org\/10.1017\/cjn.2025.10388","DOI":"10.1017\/cjn.2025.10388"},{"key":"2559_CR15","doi-asserted-by":"publisher","unstructured":"Hewitt JE, Lyle R, Clark LN, Valleley EM, Wright TJ, Wijmenga C, Van Deutekom JCt, Francis F, Sharpe PT, Hofker M, Frants RR, Williamson R (1994) Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystropothhy. Hum Mol Genet 3(8). https:\/\/doi.org\/10.1093\/hmg\/3.8.1287","DOI":"10.1093\/hmg\/3.8.1287"},{"key":"2559_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/mus.70007","author":"SN Kilburn","year":"2025","unstructured":"Kilburn SN, Thomas S, Havlik AL, Mathews KD, Street N, Soim A (2025) Hearing loss, retinal abnormality, and seizures in people with facioscapulohumeral muscular dystrophy. Muscle Nerve. https:\/\/doi.org\/10.1002\/mus.70007","journal-title":"Muscle Nerve"},{"key":"2559_CR17","doi-asserted-by":"publisher","unstructured":"Kunishima S, Okuno Y, Yoshida K, Shiraishi Y, Sanada M, Muramatsu H, Chiba K, Tanaka H, Miyazaki K, Sakai M, Ohtake M, Kobayashi R, Iguchi A, Niimi G, Otsu M, Takahashi Y, Miyano S, Saito H, Kojima S, Ogawa S (2013) ACTN1 mutations cause congenital macrothrombocytopenia. Am J Hum Genet 92(3). https:\/\/doi.org\/10.1016\/j.ajhg.2013.01.015","DOI":"10.1016\/j.ajhg.2013.01.015"},{"key":"2559_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/science.1189044","author":"RJLF Lemmers","year":"2010","unstructured":"Lemmers RJLF, Van Der Vliet PJ, Klooster R, Sacconi S, Cama\u00f1o P, Dauwerse JG, Snider L, Straasheijm KR, Van Ommen GJ, Padberg GW, Miller DG, Tapscott SJ, Tawil R, Frants RR, Van Der Maarel SM (2010) A unifying genetic model for facioscapulohumeral muscular dystrophy. Science. https:\/\/doi.org\/10.1126\/science.1189044","journal-title":"Science"},{"key":"2559_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2454","author":"RJLF Lemmers","year":"2012","unstructured":"Lemmers RJLF, Tawil R, Petek LM, Balog J, Block GJ, Santen GWE, Amell AM, Van Der Vliet PJ, Almomani R, Straasheijm KR, Krom YD, Klooster R, Sun Y, Den Dunnen JT, Helmer Q, Donlin-Smith CM, Padberg GW, Van Engelen BGM, De Greef JC, Van Der Maarel SM (2012) Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet. https:\/\/doi.org\/10.1038\/ng.2454","journal-title":"Nat Genet"},{"key":"2559_CR40","doi-asserted-by":"publisher","unstructured":"Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, and Simmerling C (2015) ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput 11(8). https:\/\/doi.org\/10.1021\/acs.jctc.5b00255","DOI":"10.1021\/acs.jctc.5b00255"},{"key":"2559_CR20","doi-asserted-by":"publisher","unstructured":"Moriggi M, Ruggiero L, Torretta E, Zoppi D, Arosio B, Ferri E, Castegna A, Fiorillo C, Gelfi C, Capitanio D (2024) Muscle proteome analysis of facioscapulohumeral dystrophy patients reveals a metabolic rewiring promoting oxidative\/reductive stress contributing to the loss of muscle function. Antioxidants 13(11). https:\/\/doi.org\/10.3390\/antiox13111406","DOI":"10.3390\/antiox13111406"},{"key":"2559_CR21","doi-asserted-by":"publisher","unstructured":"Mostacciuolo ML, Pastorello E, Vazza G, Miorin M, Angelini C, Tomelleri G, Galluzzi G, Trevisan C, Pietro (2009) Facioscapulohumeral muscular dystrophy: Epidemiological and molecular study in a north-east Italian population sample. Clin Genet 75(6). https:\/\/doi.org\/10.1111\/j.1399-0004.2009.01158.x","DOI":"10.1111\/j.1399-0004.2009.01158.x"},{"key":"2559_CR22","doi-asserted-by":"publisher","unstructured":"Nakamura F, Pudas R, Heikkinen O, Permi P, Kilpel\u00e4inen I, Munday AD, Hartwig JH, Stossel TP, Yl\u00e4nne J (2006) The structure of the GPIb-filamin A complex. Blood 107(5). https:\/\/doi.org\/10.1182\/blood-2005-10-3964","DOI":"10.1182\/blood-2005-10-3964"},{"key":"2559_CR23","doi-asserted-by":"publisher","unstructured":"Oldfors A (2007) Hereditary myosin myopathies. In Neuromuscular Disorders (Vol. 17, Number 5). https:\/\/doi.org\/10.1016\/j.nmd.2007.02.008","DOI":"10.1016\/j.nmd.2007.02.008"},{"key":"2559_CR24","doi-asserted-by":"publisher","unstructured":"Quintero J, Saad NY, Pagnoni SM, Jacquelin DK, Gatica LV, Harper SQ, Rosa AL (2022) The DUX4 protein is a co-repressor of the progesterone and glucocorticoid nuclear receptors. FEBS Lett 596(20). https:\/\/doi.org\/10.1002\/1873-3468.14416","DOI":"10.1002\/1873-3468.14416"},{"key":"2559_CR25","doi-asserted-by":"publisher","unstructured":"Ricci E, Galluzzi G, Deidda G, Cacurri S, Colantoni L, Merico B, Piazzo N, Servidei S, Vigneti E, Pasceri V, Silvestri G, Mirabella M, Mangiola F, Tonali P, Felicetti L (1999) Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol 45(6). https:\/\/doi.org\/10.1002\/1531-8249(199906)45:6%3C;751::AID-ANA9%3E;3.0.CO;2-M","DOI":"10.1002\/1531-8249(199906)45:6%3C;751::AID-ANA9%3E;3.0.CO;2-M"},{"key":"2559_CR26","doi-asserted-by":"publisher","unstructured":"Sanson B, Slioui A, Garcia J, Klouvi L, Lejeune J, Stalens C, Guien C, Rabarimeriarijaona S, Bernard R, Nectoux J, Attarian S, B\u00e9dat-Millet AL, Bouhour F, Boyer FC, Chanson JB, Choumert A, Cintas P, De La Cruz E, F\u00e9asson L, Sacconi S (2025) Prevalence and predictors of uncommon features in FSHD1 patients: insights from the French FSHD registry. Orphanet J Rare Dis 20(1). https:\/\/doi.org\/10.1186\/s13023-025-03877-z","DOI":"10.1186\/s13023-025-03877-z"},{"key":"2559_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-025-01401-6","author":"M Sasaki-Honda","year":"2025","unstructured":"Sasaki-Honda M, Kishimoto T, Sakurai H (2025) Diversity challenges and reconciles genetics in facioscapulohumeral muscular dystrophy. J Hum Genet. https:\/\/doi.org\/10.1038\/s10038-025-01401-6","journal-title":"J Hum Genet"},{"key":"2559_CR28","doi-asserted-by":"publisher","unstructured":"Serrano L, Sancho J, Hirshberg M, Fersht AR (1992) \u03b1-Helix stability in proteins. I. Empirical correlations concerning substitution of side-chains at the N and C-caps and the replacement of alanine by glycine or serine at solvent-exposed surfaces. J Mol Biol 227(2). https:\/\/doi.org\/10.1016\/0022-2836(92)90906-Z","DOI":"10.1016\/0022-2836(92)90906-Z"},{"key":"2559_CR29","doi-asserted-by":"publisher","unstructured":"Strafella C, Caputo V, Bortolani S, Torchia E, Megalizzi D, Trastulli G, Monforte M, Colantoni L, Caltagirone C, Ricci E, Tasca G, Cascella R, Giardina E (2023) Whole exome sequencing highlights rare variants in CTCF, DNMT1, DNMT3A, EZH2 and SUV39H1 as associated with FSHD. Front Genet 14. https:\/\/doi.org\/10.3389\/fgene.2023.1235589","DOI":"10.3389\/fgene.2023.1235589"},{"key":"2559_CR30","doi-asserted-by":"publisher","unstructured":"Tajsharghi H, Hammans S, Lindberg C, Lossos A, Clarke NF, Mazanti I, Waddell LB, Fellig Y, Foulds N, Katifi H, Webster R, Raheem O, Udd B, Argov Z, Oldfors A (2014) Recessive myosin myopathy with external ophthalmoplegia associated with MYH2 mutations. Eur J Hum Genet 22(6). https:\/\/doi.org\/10.1038\/ejhg.2013.250","DOI":"10.1038\/ejhg.2013.250"},{"key":"2559_CR31","doi-asserted-by":"publisher","unstructured":"Takeichi T, Torrelo A, Lee JYW, Ohno Y, Lozano ML, Kihara A, Liu L, Yasuda Y, Ishikawa J, Murase T, Rodrigo AB, Fern\u00e1ndez-Crehuet P, Toi Y, Mellerio J, Rivera J, Vicente V, Kelsell DP, Nishimura Y, Okuno Y, McGrath JA (2017) Biallelic mutations in KDSR disrupt ceramide synthesis and result in a spectrum of keratinization disorders associated with thrombocytopenia. J Invest Dermatology 137(11). https:\/\/doi.org\/10.1016\/j.jid.2017.06.028","DOI":"10.1016\/j.jid.2017.06.028"},{"key":"2559_CR32","unstructured":"The jamovi (2024) The Jamovi Project (Version 2.5) [Computer Software]. In Retrieved from https:\/\/www.jamovi.org"},{"key":"2559_CR33","doi-asserted-by":"publisher","DOI":"10.1370\/afm.983","author":"JM Valderas","year":"2009","unstructured":"Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M (2009) Defining comorbidity: implications for understanding health and health services. Ann Fam Med. https:\/\/doi.org\/10.1370\/afm.983","journal-title":"Ann Fam Med"},{"key":"2559_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20625","author":"PGM Van Overveld","year":"2005","unstructured":"Van Overveld PGM, Enthoven L, Ricci E, Rossi M, Felicetti L, Jeanpierre M, Winokur ST, Frants RR, Padberg GW, Van Der Maarel SM (2005) Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophy. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.20625","journal-title":"Ann Neurol"},{"key":"2559_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026820","author":"C Vanderplanck","year":"2011","unstructured":"Vanderplanck C, Ansseau E, Charron S, Stricwant N, Tassin A, Laoudj-Chenivesse D, Wilton SD, Copp\u00e9e F, Belayew A (2011) The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0026820","journal-title":"PLoS One"},{"key":"2559_CR37","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.12.1.417","author":"A Weiss","year":"1996","unstructured":"Weiss A, Leinwand LA (1996) The mammalian myosin heavy chain gene family. Annu Rev Cell Dev Biol. https:\/\/doi.org\/10.1146\/annurev.cellbio.12.1.417","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2559_CR38","doi-asserted-by":"publisher","unstructured":"Zatz M, Marie SK, Cerqueira A, Vainzof M, Pavanello RCM, Passos-Bueno MR (1998) The facioscapulohumeral muscular dystrophy (FSHD1) gene affects males more severely and more frequently than females. Am J Med Genet 77(2). https:\/\/doi.org\/10.1002\/(SICI)1096-8628(19980501)77:2%3C;155::AID-AJMG9%3E;3.0.CO;2-R","DOI":"10.1002\/(SICI)1096-8628(19980501)77:2%3C;155::AID-AJMG9%3E;3.0.CO;2-R"},{"issue":"2","key":"2559_CR39","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/brain\/awae309","volume":"148","author":"F Zheng","year":"2025","unstructured":"Zheng F, Lin Y, Qiu L, Zheng Y, Zeng M, Lin X, He Q, Lin Y, Chen L, Lin X, Chen X, Lin L, Wang L, He J, Lin F, Yang K, Wang N, Lin M, Lian S, Wang Z (2025) Age at onset mediates genetic impact on disease severity in facioscapulohumeral muscular dystrophy. Brain 148(2):613\u2013625. https:\/\/doi.org\/10.1093\/brain\/awae309","journal-title":"Brain"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-026-02559-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-026-02559-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-026-02559-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:34:13Z","timestamp":1790177653000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-026-02559-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["2559"],"URL":"https:\/\/doi.org\/10.1007\/s12031-026-02559-0","relation":{},"ISSN":["1559-1166"],"issn-type":[{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"109"}}